Mohammad Purfakharan
, Tehran University of Medical Sciences, Tehran, Iran.
[ 1 ] - Effect of Zafirlukast on improving lung function in patients with chronic obstructive pulmonary diseases
Background : There is little evidence about the role of Zafirlukast (a highly selective LTD4 antagonist) in Chronic Obstructive Pulmonary Disease (COPD). The Zafirlukast can reduce the need for short-acting rescue β2 agonists, produce fewer exacerbations of asthma and increased quality of life as possible benefits treatment for asthma. The aim of our study was to evaluate the effects of Zafir...
نویسندگان همکار